Drug Toxicity Psychotropic Agents Psychostimulants Terminated Phase 2 Trials for Dantrolene (DB01219)

IndicationStatusPhase
DBCOND0111562 (Drug Toxicity Psychotropic Agents Psychostimulants)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03189433
Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)Treatment